Recent Finacing
Recent Raise
Small Pharma identifies and advances academically derived drug candidates using IP-driven project selection, developing oral ketamine-metabolite and 5‑HT2A agonist rapid-acting antidepressants through formulation and proof-of-concept clinical trials.
